Lowell Farms Past Earnings Performance
Past criteria checks 0/6
Lowell Farms's earnings have been declining at an average annual rate of -0.07%, while the Pharmaceuticals industry saw earnings growing at 31.5% annually. Revenues have been growing at an average rate of 6.1% per year.
Key information
-0.07%
Earnings growth rate
38.0%
EPS growth rate
| Pharmaceuticals Industry Growth | 23.1% |
| Revenue growth rate | 6.1% |
| Return on equity | -325.3% |
| Net Margin | -132.1% |
| Last Earnings Update | 31 Dec 2023 |
Recent past performance updates
Recent updates
Is Lowell Farms (CSE:LOWL) A Risky Investment?
Aug 31
Further Upside For Lowell Farms Inc. (CSE:LOWL) Shares Could Introduce Price Risks After 33% Bounce
Apr 17Analysts Are Optimistic We'll See A Profit From Indus Holdings, Inc. (CSE:INDS)
Jan 29
The Indus Holdings (CSE:INDS) Share Price Is Up 280% And Shareholders Are Boasting About It
Dec 07Revenue & Expenses BreakdownBeta
How Lowell Farms makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 31 Dec 23 | 28 | -37 | 10 | 0 |
| 30 Sep 23 | 30 | -35 | 10 | 0 |
| 30 Jun 23 | 33 | -20 | 11 | 0 |
| 31 Mar 23 | 39 | -25 | 13 | 0 |
| 31 Dec 22 | 44 | -25 | 15 | 0 |
| 30 Sep 22 | 49 | -23 | 17 | 0 |
| 30 Jun 22 | 53 | -27 | 20 | 0 |
| 31 Mar 22 | 55 | -22 | 22 | 0 |
| 31 Dec 21 | 54 | -25 | 22 | 0 |
| 30 Sep 21 | 48 | -19 | 21 | 0 |
| 30 Jun 21 | 49 | -11 | 20 | 0 |
| 31 Mar 21 | 44 | -21 | 16 | 0 |
| 31 Dec 20 | 43 | -22 | 17 | 0 |
| 30 Sep 20 | 44 | -35 | 23 | 0 |
| 30 Jun 20 | 40 | -54 | 27 | 0 |
| 31 Mar 20 | 40 | -53 | 33 | 0 |
| 31 Dec 19 | 37 | -50 | 32 | 0 |
| 30 Sep 19 | 33 | -36 | 25 | 0 |
| 30 Jun 19 | 28 | -17 | 19 | 0 |
| 31 Mar 19 | 21 | -11 | 13 | 0 |
| 31 Dec 18 | 17 | -9 | 11 | 0 |
| 31 Dec 17 | 15 | -7 | 8 | 0 |
| 31 Dec 16 | 5 | -3 | 4 | 0 |
Quality Earnings: LOWL is currently unprofitable.
Growing Profit Margin: LOWL is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: LOWL is unprofitable, and losses have increased over the past 5 years at a rate of 0.07% per year.
Accelerating Growth: Unable to compare LOWL's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: LOWL is unprofitable, making it difficult to compare its past year earnings growth to the Pharmaceuticals industry (22%).
Return on Equity
High ROE: LOWL has a negative Return on Equity (-325.34%), as it is currently unprofitable.